Global Transplantation Market 2015-2019

Global Transplantation Market 2015-2019

Category : Pharmaceuticals
Published On : February  2015
Pages : 112



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About Transplantation
Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced with specific alternative tissues. Kidney transplantation is the most common transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal grafts transplantations are the most common tissue transplantation procedures. The following are the products required during a transplantation procedure: transplantation tissue products, immunosuppressant drugs, and organ preservation solutions. 

TechNavio's analysts forecast the Global Transplantation market to grow at a CAGR of 9.36 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of Global Transplantation market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of transplantation tissue products, immunosuppressant drugs, and organ preservation solutions. These products are used for many transplantation procedures including 

• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation 
• Pancreas transplantation
• Other transplantation

TechNavio's report, the Global Transplantation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Transplantation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas 
• APAC
• EMEA   
     
Key Vendors
• Abbott Laboratories
• Arthrex
• Biomet
• Kinetic Concepts
• Medtronic
• Novartis
• Stryker 

Other Prominent Vendors
 • 21st Century Medicine 
• Aastrom Biosciences
• Accord Healthcare 
• Acologix
• Actavis
• Advanced Cell Technology
• Allosource
• Arteriocyte
• Astellas Pharma
• Athersys
• Avita Medical
• Bacterin International
• Baxter 
• Bellicum Pharmaceuticals
• Bioactive Regenerative Therapeutics
• BioCardia
• BioLife Solutions
• Bio-Rad Laboratories
• BioTime
• Bridge to Life 
• Bristol-Myers Squibb
• Cell & Tissue Systems
• Claris Lifesciences
• CONMED
• Cryolife 
• Cynata Therapeutics
• Cytomedix
• Cytori Therapeutics
• Dr. F. Köhler Chemie 
• Edwards Lifesciences 
• Exactech 
• Forticell Bioscience
• GE Healthcare
• Genzyme 
• Geron
• GlaxoSmithKline 
• Harvard Apparatus Regenerative Technologies
• HeartWare 
• Histogenics
• Humacyte
• F. Hoffmann-La Roche
• Integra Lifescience
• InVivo Therapeutics
• Johnson & Johnson
• Kensey Nash
• Kiadis Pharma
• Lifeblood Medical
• Lifeline Scientific 
• Living Cell Technologies 
• Luminex 
• MaxCyte
• Mesoblast
• Nanofiber Solutions CTO
• NeoStem
• Neuralstem
• On-X Life Technologies 
• Opexa Therapeutics
• Organ Recovery Systems
• Organogenesis 
• Osiris Therapeutics
• Osteotech
• Pfizer 
• Pluristem Therapeutics
• Preservation Solutions
• Quest Diagnostics
• ReNeuron 
• RTI Surgical 
• SanBio
• Smith & Nephew 
• St. Jude Medical 
• StemCells
• Syncardia Systems 
• Tengion
• Terumo Medical 
• Teva Pharmaceuticals 
• Thermo Fischer Scientific
• Thoratec 
• Tissue Genesis
• ToleroTech
• TransMedics
• Veloxis Pharmaceuticals 
• ViaCyte
• Xvivo Perfusion
• Zimmer   

Market Driver
• Increased Incidence of Organ Failure
• For a full, detailed list, view our report

Market Challenge
• Transplant Rejection 
• For a full, detailed list, view our report

Market Trend
• Increased Government and NGO Initiatives
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?



01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Overview

06.1 Organ Transplants Performed in Americas

06.2 Organ Transplants Performed in Europe Region

06.3 Organ Transplants Performed in APAC Region

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Application

09. Market Segmentation by Product Type

09.1 Global Transplantation Tissue Products Market

09.1.1 Market Size and Forecast

09.2 Global Immunosuppressant Drugs Market

09.2.1 Market Size and Forecast

09.3 Global Tissue Typing Technologies and Organ Preservation Solutions Market

09.3.1 Market Size and Forecast

09.4 Global Alternative Technologies Market

09.4.1 Market Size and Forecast

10. Geographical Segmentation

10.1 Transplantation Market in Americas

10.1.1 Market Size and Forecast

10.2 Transplantation Market in EMEA Region

10.2.1 Market Size and Forecast

10.3 Transplantation Market in APAC Region

10.3.1 Market Size and Forecast

11. Key Leading Countries

11.1 US

11.2 UK

11.3 France

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Vendor Analysis 2014

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Abbott Laboratories

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Revenue by Business Segmentation

20.1.6 Revenue Comparison 2011 and 2012

20.1.7 Revenue by Geographical Segmentation

20.1.8 Key Information

20.1.9 SWOT Analysis

20.2 Arthrex

20.2.1 Key Facts

20.2.2 Business Overview

20.2.3 Product Groups

20.2.4 Key Locations

20.2.5 Recent Developments

20.2.6 SWOT Analysis

20.3 Biomet

20.3.1 Key Facts

20.3.2 Business Overview

20.3.3 Product Segmentation by Revenue 2014

20.3.4 Product Segmentation by Revenue 2013 and 2014

20.3.5 Geographical Segmentation by Revenue 2014

20.3.6 Business Strategy

20.3.7 Recent Developments

20.3.8 SWOT Analysis

20.4 Kinetic Concepts

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Business Segmentation

20.4.4 Business Segmentation by Revenue 2013

20.4.5 Sales by Geography

20.4.6 Business Strategy

20.4.7 Recent Developments

20.4.8 SWOT Analysis

20.5 Medtronic

20.5.1 Key Facts

20.5.2 Business Overview

20.5.3 Business Segmentation by Revenue 2013

20.5.4 Business Segmentation by Revenue 2012 and 2013

20.5.5 Geographical Segmentation by Revenue 2013

20.5.6 Business Strategy

20.5.7 Recent Developments

20.5.8 SWOT Analysis

20.6 Novartis

20.6.1 Key Facts

20.6.2 Business Description

20.6.3 Business Segmentation

20.6.4 Revenue by Business Segmentation

20.6.5 Revenue Comparison 2012 and 2013

20.6.6 Sales by Geography

20.6.7 Business Strategy

20.6.8 Key Developments

20.6.9 SWOT Analysis

20.7 Stryker

20.7.1 Key Facts

20.7.2 Business Overview

20.7.3 Business Segmentation by Revenue 2013

20.7.4 Business Segmentation by Revenue 2012 and 2013

20.7.5 Geographical Segmentation by Revenue 2013

20.7.6 Business Strategy

20.7.7 Recent Developments

20.7.8 SWOT Analysis

21. Other Reports in this Series



List of Exhibits



Exhibit 1: Market Research Methodology

Exhibit 2: Transplant Procedures Performed Americas 2013

Exhibit 3: Transplant Procedures Performed Europe Region 2013

Exhibit 4: Transplant Procedures Performed APAC Region 2013

Exhibit 5: Global Transplantation Market 2014-2019 (US$ billion)

Exhibit 6: Segmentation of Global Transplantation Market by Application

Exhibit 7: Segmentation of Global Transplantation Market by Application 2014

Exhibit 8: Segmentation of Global Transplantation Market by Product Type

Exhibit 9: Segmentation of Global Transplantation Market by Product Type 2014 and 2019

Exhibit 10: Global Transplantation Tissue Products Market 2014-2019 (US$ billion)

Exhibit 11: Global Immunosuppressant Drugs Market 2014-2019 (US$ billion)

Exhibit 12: Global Tissue Typing Technologies and Organ Preservation Solutions Market 2014-2019 (US$ billion)

Exhibit 13: Global Alternative Technologies Market 2014-2019 (US$ billion)

Exhibit 14: Segmentation of Global Transplantation Market by Product Type 2014-2019 (in billion)

Exhibit 15: Segmentation of Global Transplantation Market by Product Type 2014-2019

Exhibit 16: Segmentation of Global Transplantation Market by Geography 2014 and 2019

Exhibit 17: Transplantation Market in Americas 2014-2019 (US$ billion)

Exhibit 18: Transplantation Market in EMEA Region 2014-2019 (US$ billion)

Exhibit 19: Transplantation Market in APAC Region 2014-2019 (US$ billion)

Exhibit 20: Global Transplantation Market Segmentation by Geography 2014-2019 (US$ billion)

Exhibit 21: Global Transplantation Market Segmentation by Geography 2014-2019

Exhibit 22: Abbott Laboratories Inc.: Business Segmentation

Exhibit 23: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012

Exhibit 24: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)

Exhibit 25: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012

Exhibit 26: Arthrex: Product Groups

Exhibit 27: Arthrex: Key Locations

Exhibit 28: Biomet: Product Segmentation by Revenue 2014

Exhibit 29: Biomet: Product Segmentation by Revenue 2013 and 2014 (US$ million)

Exhibit 30: Biomet: Geographical Segmentation by Revenue 2014

Exhibit 31: Kinetic Concepts: Business Segmentation 2013

Exhibit 32: Kinetic Concepts: Business Segmentation by Revenue 2013

Exhibit 33: Kinetic Concepts: Sales by Geography 2013

Exhibit 34: Medtronic: Business Segmentation by Revenue 2013

Exhibit 35: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)

Exhibit 36: Medtronic: Geographical Segmentation by Revenue 2013

Exhibit 37: Novartis AG: Business Segmentation

Exhibit 38: Novartis AG: Revenue by Business Segmentation 2013

Exhibit 39: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)

Exhibit 40: Novartis AG: Revenue by Geographical Segmentation 2013

Exhibit 41: Stryker: Business Segmentation by Revenue 2013

Exhibit 42: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)

Exhibit 43: Stryker: Geographical Segmentation by Revenue 2013


Enquiry Before Buy
image
Can´t read the image ? refresh here.